Asia-Pacific Radiotherapy Market by Type (External Beam Radiation Therapy (Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic body Radiation Therapy and Proton Therapy), Internal Beam Radiation Therapy and Systemic Radiation Therapy), by Application (Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer), by Equipment Type (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Asia-Pacific Radiotherapy Market by Type (External Beam Radiation Therapy (Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Tomotherapy, Stereotactic Radiosurgery, Stereotactic body Radiation Therapy and Proton Therapy), Internal Beam Radiation Therapy and Systemic Radiation Therapy), by Application (Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer), by Equipment Type (Linear Accelerators, Radiation Therapy Simulators and Treatment Planning Systems) and by Region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 818 | Pages: 145 | October 2016 | Region: Asia Pacific


The Asia-Pacific Radiotherapy Market was worth $1,144.5 million in 2016 and estimated to be growing at a CAGR of 6.82%, to reach $1,591.7 million by 2021. Asia-Pacific radiotherapy market is expected to observe highest growth rate during the forecast period owing to a number of factors comprising refining healthcare infrastructure and supportive government activities.

In the present global state where number of people bearing with different types of cancer is on the growth, the applications of new and upgraded as well as conventional forms of radiotherapy are enormous. The supreme important necessity requiring the development of improved and progressively precise radiation therapy is the requirement to exactly hit only the affected tumour using the radiation beam and avoid harming the surrounding tissue.

Increase in number of elderly population, technological innovations in radiotherapy products, rising conferences driving investments in radiotherapy, growing incidence of cancer incidences and mounting acceptance of radiotherapy devices and procedures will majorly drive the radiotherapy market. Though, the absence of trained personnel to perform the therapy, practiced alternative therapy, its incapability to be used for metastasis state of cancer and side effects associated with the treatment restrained the market growth.

The Asia-Pacific radiotherapy market is segmented on the basis of type into External beam radiation therapy, internal beam radiation therapy and systemic radiation therapy. External beam radiation therapy is sub segmented into Intensity-modulated radiation therapy (IMRT), Image-guided radiation therapy (IGRT), Tomotherapy, Stereotactic radiosurgery, Stereotactic body radiation therapy and Proton therapy. Based on application the market is segregated into Skin & Lip Cancer, Head & Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer and Spine Cancer. On the basis of equipment type market is bifurcated into Linear accelerators, Radiation therapy simulators and Treatment planning systems. The prostate cancer application segment is estimated to hold the largest share in both external beam radiotherapy market along with internal radiotherapy market.

Based on geography the market is analysed under various regions namely, China, India, Japan, South Korea and Australia. China is dominating the Asia-Pacific region radiotherapy market due to large number of elderly population in the country and is expected to continue its dominance.

Nordion Inc. (Canada), RaySearch Laboratories AB (Sweden), Ion Beam Applications SA (Belgium), C. R. Bard Inc. (U.S.), Mevion Medical Systems Inc. (U.S.), Varian Medical Systems Inc. (U.S.), IsoRay Medical Inc. (U.S.), Elekta AB (Sweden), Accuray Incorporated (U.S.), and Mitsubishi Electric Corporation (Japan) are the key players in the radiotherapy market.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 By Type                        

                                5.1.1 External Beam Radiation Therapy

                                                5.1.1.1 Intensity-Modulated Radiation Therapy (IMRT)

                                                5.1.1.2 Image-Guided Radiation Therapy (IGRT)

                                                5.1.1.3 Tomotherapy

                                                5.1.1.4 Stereotactic Radiosurgery

                                                5.1.1.5 Stereotactic body Radiation Therapy

                                                5.1.1.6 Proton Therapy

                                5.1.2 Internal Beam Radiation Therapy  

                                5.1.3 Systemic Radiation Therapy             

                5.2 By Application                           

                                5.2.1 Skin & Lip Cancer  

                                5.2.2 Head & Neck Cancer           

                                5.2.3 Breast Cancer        

                                5.2.4 Prostate Cancer    

                                5.2.5 Cervical Cancer      

                                5.2.6 Lung Cancer            

                                5.2.7 Spine Cancer          

                5.3 By Equipment Type                 

                                5.3.1 Linear Accelerators              

                                5.3.2 Radiation Therapy Simulators         

                                5.3.3 Treatment Planning Systems          

6. Geographical Analysis                                              

                6.3 Asia-Pacific                 

                                6.1 Introduction               

                                6.2 China             

                                6.3 India              

                                6.4 Japan            

                                6.5 South Korea               

                                6.6 Australia      

7. Pipeline Product Analysis                                        

                7.1 Overview                                    

                7.2 Pipeline Development Landscape                                    

                7.3 Molecular Targets in the Pipeline                                      

                7.4 Clinical Trials                               

                                7.4.1 Failure Rate by Stage of Development, Indication, Molecule Type and Molecular Target     

                                7.4.2 Clinical Trial Duration by Stage of Development, Indication, Molecule Type and Molecular Target   

                                7.4.3 Clinical Trial Size by Stage of Development, Indication, Molecule Type and Molecular Target.            

8. Strategic Analysis                                       

                8.1 PESTLE analysis                         

                                8.1.1 Political     

                                8.1.2 Economic 

                                8.1.3 Social         

                                8.1.4 Technological         

                                8.1.5 Legal          

                                8.1.6 Environmental       

                8.2 Porter’s Five analysis                              

                                8.2.1 Bargaining Power of Suppliers        

                                8.2.2 Bargaining Power of Consumers    

                                8.2.3 Threat of New Entrants     

                                8.2.4 Threat of Substitute Products and Services              

                                8.2.5 Competitive Rivalry within the Industry     

9. Market Leaders' Analysis                                        

                9.1 Nordion Inc.                               

                                9.1.1 Overview 

                                9.1.2 Product Analysis   

                                9.1.3 Strategic Evaluation and Operations            

                                9.1.4 Financial analysis  

                                9.1.5 Legal issues             

                                9.1.6 Recent Developments       

                                9.1.7 SWOT analysis       

                                9.1.8 Analyst View          

                9.2 RaySearch Laboratories AB                  

                9.3 Ion Beam Applications SA                     

                9.4 C. R. Bard Inc.                            

                9.5 Mevion Medical Systems Inc.                             

                9.6 Varian Medical Systems Inc.                                

                9.7 IsoRay Medical Inc.                 

                9.8 Elekta AB                     

                9.9 Accuray Incorporated                            

                9.10 Mitsubishi Electric Corporation                        

10. Competitive Landscape                                         

                10.1 Market share analysis                          

                10.2 Merger and Acquisition Analysis                     

                10.3 Agreements, collaborations and Joint Ventures                      

                10.4 New Product Launches                       

11. Expert Opinions                                        

                11.1 Market Outlook                     

                11.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Asia-Pacific Radiotherapy Market By Region, From 2016-2021 (USD Million)
  2. Asia-Pacific Radiotherapy Market By Type, From 2016-2021 (USD Million)
  3. Asia-Pacific External Beam Radiation Therapy Market By Region, From 2016-2021 (USD Million)
  4. Asia-Pacific Radiotherapy Market By External Beam Radiation Therapy Type, From 2016-2021 (USD Million)
  5. Asia-Pacific Intensity-Modulated Radiation Therapy (IMRT) Market By Region, From 2016-2021 (USD Million)
  6. Asia-Pacific Image-Guided Radiation Therapy (IGRT) Market By Region, From 2016-2021 (USD Million)
  7. Asia-Pacific Tomotherapy Market By Region, From 2016-2021 (USD Million)
  8. Asia-Pacific Stereotactic Radiosurgery Market By Region, From 2016-2021 (USD Million)
  9. Asia-Pacific Stereotactic body Radiation Therapy Market By Region, From 2016-2021 (USD Million)
  10. Asia-Pacific Proton Therapy Market By Region, From 2016-2021 (USD Million)
  11. Asia-Pacific Internal Beam Radiation Therapy Market By Region, From 2016-2021 (USD Million)
  12. Asia-Pacific Systemic Radiation Therapy Market By Region, From 2016-2021 (USD Million)
  13. Asia-Pacific Radiotherapy Market By Application, From 2016-2021 (USD Million)
  14. Asia-Pacific Skin & Lip Cancer Market By Region, From 2016-2021 (USD Million)
  15. Asia-Pacific Head & Neck Cancer Market By Region, From 2016-2021 (USD Million)
  16. Asia-Pacific Breast Cancer Market By Region, From 2016-2021 (USD Million)
  17. Asia-Pacific Prostate Cancer Market By Region, From 2016-2021 (USD Million)
  18. Asia-Pacific Cervical Cancer Market By Region, From 2016-2021 (USD Million)
  19. Asia-Pacific Lung Cancer Market By Region, From 2016-2021 (USD Million)
  20. Asia-Pacific Spine Cancer Market By Region, From 2016-2021 (USD Million)
  21. Asia-Pacific Radiotherapy Market By Equipment Type, From 2016-2021 (USD Million)
  22. Asia-Pacific Linear Accelerators Market By Region, From 2016-2021 (USD Million)
  23. Asia-Pacific Radiation Therapy Simulators Market By Region, From 2016-2021 (USD Million)
  24. Asia-Pacific Treatment Planning Systems Market By Region, From 2016-2021 (USD Million)
  25. China Radiotherapy Market By Type, From 2016-2021 (USD Million)
  26. China Radiotherapy Market By External Beam Radiation Therapy Type, From 2016-2021 (USD Million)
  27. China Radiotherapy Market By Application, From 2016-2021 (USD Million)
  28. China Radiotherapy Market By Equipment Type, From 2016-2021 (USD Million)
  29. India Radiotherapy Market By Type, From 2016-2021 (USD Million)
  30. India Radiotherapy Market By External Beam Radiation Therapy Type, From 2016-2021 (USD Million)
  31. India Radiotherapy Market By Application, From 2016-2021 (USD Million)
  32. India Radiotherapy Market By Equipment Type, From 2016-2021 (USD Million)
  33. Japan Radiotherapy Market By Type, From 2016-2021 (USD Million)
  34. Japan Radiotherapy Market By External Beam Radiation Therapy Type, From 2016-2021 (USD Million)
  35. Japan Radiotherapy Market By Application, From 2016-2021 (USD Million)
  36. Japan Radiotherapy Market By Equipment Type, From 2016-2021 (USD Million)
  37. South Korea Radiotherapy Market By Type, From 2016-2021 (USD Million)
  38. South Korea Radiotherapy Market By External Beam Radiation Therapy Type, From 2016-2021 (USD Million)
  39. South Korea Radiotherapy Market By Application, From 2016-2021 (USD Million)
  40. South Korea Radiotherapy Market By Equipment Type, From 2016-2021 (USD Million)
  41. Australia Radiotherapy Market By Type, From 2016-2021 (USD Million)
  42. Australia Radiotherapy Market By External Beam Radiation Therapy Type, From 2016-2021 (USD Million)
  43. Australia Radiotherapy Market By Application, From 2016-2021 (USD Million)
  44. Australia Radiotherapy Market By Equipment Type, From 2016-2021 (USD Million)
Middle East And Africa Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Gr...
Latin America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Asia Pacific Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tren...
Europe Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Trends, An...
North America Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region (Industry Analysis, Size, Share, Growth, Tre...
Schizoaffective Disorders Treatment Market By Treatment (Antipsychotics, Mood Stabilisers, Antidepressants, Anticonvulsants And Psychotherapy) And By Region Global (Industry Analysis, Size, Share, Growth, Trends, An...
Middle East And Africa Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022...
Latin America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Asia Pacific Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Europe Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
North America Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...
Theranostics Market By Diseases (Neurological Disorders, Cancers, Cardiovascular Diseases And Others) And By Region -Global Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2017–2022)...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.